BlueStar Genomic Health Care Index

The BlueStar Genomic Health Care Index (BDNANTR) tracks the performance of the largest and most liquid companies in the global genomic healthcare industry. This is a modified market cap-weighted index, and only includes companies that generate at least 50% of their revenue from health care therapies based on targeting or the modification of the genetic makeup of cells or uses mRNA, technology platforms that enable the development of genetics-based health care thearpies, or laboratory equipment or services used to test, code, or develop genetics-based health care companies.

Key Features

Size and Liquidity RequirementsFloat-adjusted market capitalization of at least 300 mln USD. Six-month average-daily-value-traded of at least 200000 USD.
Universe Companies developing or producing gene-based healthcare technologies and therapies.
Diversification Companies are liquidity weighted.
Review Semi-annual in June and December.
IndexLast CloseOpenLastChangeChange (1Y)Range (1Y)
 
296.98 296.98 --208.00%72.17 - 381.50
Symbol IndexName
BDNANTR BlueStar Genomic Health Care Total Return Net Index
Up